Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary...

Full description

Authors: COVID Surg Collaborative; Pujol-Cano, Natalia; Segura-Sampedro, Juan José; Soldevila Verdeguer, Carla; Jerí-McFarlane, Sebastián; Gil-Catalan, Alejandro; Craus-Miguel, Andrea; Ferrer-Inaebnit, Ester; Oseira-Reigosa, Anaí; González-Argenté, Francesc Xavier
Format: Article
Publication date:2021
Country:España
Institution:Conselleria de Salut i Consum del Govern de les Illes Balears
Repository:Docusalut
Language:English
OAI Identifier:oai:docusalut.com:20.500.13003/25571
Online Access:https://hdl.handle.net/20.500.13003/25571
Access Level:Open access
Keyword:BCG Vaccine
COVID-19
Humans
SARS-CoV-2
Vaccination
Vacuna BCG
Humanos
Vacunación
Summary:There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality.

Similar Items